Vitamin+D+Lecture 1

Embed Size (px)

Citation preview

  • 7/29/2019 Vitamin+D+Lecture 1

    1/35

    Vitamin D History1645 Whistler (1650 Glisson): rickets described

    1920 Mellanby: dogs raised indoors (no sunlight)

    developed rickets: cod liver oil cured it

    1920s McCollum: bubbling oxygen through a

    preparation of fat-soluble vitamins inactivatedvitamin A but not vitamin D

    1923 Goldblatt and Soames: skin produced a

    substance equivalent to vitamin D when irradiated bysunlight or UV light

    1920s Hess and Weinstock: skin irradiated with UV

    light and fed to rats cured rickets

  • 7/29/2019 Vitamin+D+Lecture 1

    2/35

    Rickets

    Mineralization defectHypertrophy of Chondrocytes (cartilage)

    Short stature

    Bony deformities

    In children: bowed legs

    defects in rib cage

  • 7/29/2019 Vitamin+D+Lecture 1

    3/35

    Vitamin D3 = Cholecalciferol

    Produced in animalsVitamin D2 = Ergocalciferol

    Derived from a precursor

    found in plants and yeast

  • 7/29/2019 Vitamin+D+Lecture 1

    4/35

    Dietary Sources of Vitamin D

    Fatty fish (mackerel and salmon)

    Fish oils (cod and tuna liver oils)

    Foods fortified with Vitamin D:

    MilkCereals

    Breads

    Fortified foods rarely contain the labeledamount of vitamin D

  • 7/29/2019 Vitamin+D+Lecture 1

    5/35

    Vitamin D is a fat soluble vitamin

    HydrophobicPoorly soluble in aqueous environments

    such as the intestinal lumen, plasma, and

    the cytoplasm of cells

    Hence, requires carriers or transport proteins

    in aqueous environments

    Easily soluble in lipid-rich environmentsso, crosses membranes readily and is

    stored in lipid droplets within cells

  • 7/29/2019 Vitamin+D+Lecture 1

    6/35

    Digestion and Absorption:

    Fat soluble vitamin: emulsified with lipids and

    bile acids

    Taken up into enterocytes by passive diffusion

  • 7/29/2019 Vitamin+D+Lecture 1

    7/35

    Vitamin D is

    packaged with

    dietary lipids intochylomicrons,

    secreted into lymph,

    then circulates in

    plasma. Action of

    lipoprotein lipase

    removes lipids

    into muscle and fat;some vitamin D

    stored in fat, as well.

    Chylomicron remnants then taken up by liver.

  • 7/29/2019 Vitamin+D+Lecture 1

    8/35

    7-Dehydrocholesterol can be converted to

    Vitamin D in the skin; requires UV light

    Vitamin D not strictly a vitamin since it can be produced by the body

  • 7/29/2019 Vitamin+D+Lecture 1

    9/35

    The amount of Vitamin D produced in the skin

    is reduced with the use of sunscreen

    1 minimal erythemal dose (minimum sunburn) used:equivalent to 10,000-25,000 IU of oral vitamin D

    (single exposure)

    SPF 8 sunscreenused in this

    example

    Clothing also

    reducessun exposure

  • 7/29/2019 Vitamin+D+Lecture 1

    10/35

    The ability to produce vitamin D in the skin

    varies with:

    Pigmentation: melanin levels reduce UVB to skin

    Age:Young 20-30

    Elderly 62-80

    1 exposure

    of minimal

    erythemal dose

    70 yrs: 75%

    reduction in vit.D

    production in skin

    (reduced 7-dehydrocholesterol in the skin)

  • 7/29/2019 Vitamin+D+Lecture 1

    11/35

    Vitamin D production in skin varies with:

    Time of DaySeason of year

    Latitude:

    42 = Boston; sunlight too dim to producevitamin D in the skin from November

    through February

    Stores of vitamin D in fat may be adequate toprovide vitamin D in the winter

    3 weekly exposures of hands and face for 20 min

  • 7/29/2019 Vitamin+D+Lecture 1

    12/35

    Vitamin D is

    converted to

    25-hydroxyvitamin D3

    in the liver (andalso skin, intestine,

    and kidney)

    25-OH vit D3 is

    exported from liveron vitamin D-binding

    protein (DBP)

    Metabolism to

    1,25-dihydroxyvitaminD3 occurs in kidney;

    this is the active form

    24,25(OH)2 vit. D3 is

    much less active

  • 7/29/2019 Vitamin+D+Lecture 1

    13/35

    Metabolism of Vitamin D:

    Hydroxylation of carbon 25 to make 25-OH vit. D3by 25-hydroxylase occurs primarily in liver

    (also skin, intestine and kidney)

    Export of 25-OH vit. D3 from liver into circulation on DBP25-hydroxylation is poorly regulated, hence,

    25-hydroxyvitamin D levels in plasma

    are used to determine vitamin D status

    Levels of 25-OH most accurately reflectdietary intake and cutaneous production,

    since vit. D3 is rapidly converted to 25-OH vit. D3

    and this is the major circulating form

  • 7/29/2019 Vitamin+D+Lecture 1

    14/35

    More on Metabolism

    Metabolism of 25-hydroxyvitamin D3 to the

    biologically active form occurs in thekidney: hydroxylation of carbon 1 to

    make 1,25-dihydroxyvitamin D3: export

    from kidney on DBP

    Other tissues have the 1-hydroxylase, butcontribute little to 1,25-(OH)2D levels

    Placenta during pregnancy

    Macrophages, other cells

    24-hydroxylase in kidney: makes 24,25-di-hydroxyvitamin D: less active,

    unknown function, step in degradation

    Excreted form: calcitroic acid

  • 7/29/2019 Vitamin+D+Lecture 1

    15/35

    Functions of 1,25 (OH)2Vitamin D3

    Functions as a hormone

    Primary function in whole body calcium

    and phosphorous homeostasis

    Maintenance of a healthy skeleton

    Maintain serum calcium (10 mg/

    100 ml) and phosphorous levels(4 mg/100 ml) for bone mineralization

  • 7/29/2019 Vitamin+D+Lecture 1

    16/35

    1,25 (OH)2Vit.D3 increases calcium levels:

    3 mechanisms:

    Most important: increases intestinal

    absorption of calcium

    Increases renal reabsorption of calcium

    Increases calcium mobilization from

    bone

  • 7/29/2019 Vitamin+D+Lecture 1

    17/35

    1,25(OH)2Vit. D3 is a hormone that binds to the

    Vitamin D Receptor, a transcription factor

    DNA binding domain: 2 zinc fingers

    Ligand binding domain: binds 1,25(OH)2vit. D3

    Heterodimerizes with RXR (retinoid X receptor)

    Binds to VDREs in the promoters of many genes

  • 7/29/2019 Vitamin+D+Lecture 1

    18/35

    Hormonal action of 1,25(OH)2vitamin D3

    9-cis retinoic

    acid

    Induction

    Repression of transcription

    Both increases and

    decreases in

    transcription

    of genes

    CaT1=TRPV6

  • 7/29/2019 Vitamin+D+Lecture 1

    19/35

    1,25(OH)2Vit.D3 action on Intestine

    Increases synthesis of proteins involved

    in the uptake and transport of calcium

    Increases transcription of genes:

    TRPV6/CaT1 calcium channel (epithelium)

    Calbindin, a cellular calcium bindingprotein (Ca2+ movement in cytoplasm)

    Basolateral calcium pump (export)

    Directly increases calcium absorption

    across enterocyte plasma membrane

    Increases phosphorous absorption in small

    intestine by increasingexpression of

    Na-Pi co-transporter called Npt2

  • 7/29/2019 Vitamin+D+Lecture 1

    20/35

    1,25(OH)2Vit.D3 Actions on Bone

    Bone is continually remodeled

    In osteoblasts, 1,25 (OH)2D3 increases the

    expression of osteopontin and

    osteocalcin, bone matrix proteins

    Promotes mineralization by maintenance

    of serum calcium and phosphorous levels

    When dietary calcium is low, 1,25(OH)2D3

    promotes osteoclast differentiation(involved in bone resorption; for

    mobilization of bone calcium)

  • 7/29/2019 Vitamin+D+Lecture 1

    21/35

    1,25(OH)2Vit.D3 Action on Kidney

    1,25(OH)2D3 suppresses 1-hydroxylaseactivity (decreases further production

    of 1,25(OH)2D3)

    Stimulates 24-hydroxylase activity: step

    towards removal of excess

    1,25(OH)2D3 from body

    Enhances renal calcium reabsorption

  • 7/29/2019 Vitamin+D+Lecture 1

    22/35

    1,25(OH)2Vit.D3 regulates genes

    unrelated to calcium homeostasis

    Alters transcription of genes involved in the cell

    cycle to inhibit proliferation and induce

    terminal differentiation

    c-myc, c-fos, c-cis (oncogenes)Used to treat psoriasis, a hyperproliferativeskin disorder

    Stimulates immune function

    Modulates muscle cell calcium levels and cell growth

    Pancreas: enhances insulin secretion

    Role in female fertility

    Nervous system: antiproliferative, prodifferentiation

  • 7/29/2019 Vitamin+D+Lecture 1

    23/35

    Regulation of Vitamin D Metabolism

    25-hydroxylase activity in liver is not well

    regulated

    1-hydroxylase activity in kidney is highly

    regulated through transcription

    Low 1,25(OH)2D3 in circulation:

    increase 1-hydroxylase activity to

    increase 1,25(OH)2D3 production

    High 1,25(OH)2D3 levels: decrease

    1-hydroxylase activity and increase

    24-hydroxylase activity

  • 7/29/2019 Vitamin+D+Lecture 1

    24/35

    More on Regulation of Vitamin D

    With vitamin D deficiency, intestinal calcium

    absorption decreases from 30-50% to

    10-15%; circulating calcium decreases

    Parathyroid gland calcium sensor detects Ca2+

    levels in serum and increases synthesis andproduction of parathyroid hormone (PTH)

    PTH increases renal 1-hydroxylase activity,

    to increase production of 1,25(OH)2

    Vit D3

    ,

    increases renal reabsorption of calcium,

    mobilizes osteoclasts to mobilize bone

    calcium (works through a signaling pathway

    on pre-osteoblasts)

  • 7/29/2019 Vitamin+D+Lecture 1

    25/35

    Summary of Vitamin D regulatory

    Pathway:

    25(OH)D3

    High PTH

    Low Pi

    Low Calcium 1,25(OH)2D3

    24,25(OH)2D3

    High calciumLow PTH

    High Pi

    High 1,25(OH)2D3

    24- OHase

    1-OHase

  • 7/29/2019 Vitamin+D+Lecture 1

    26/35

    VDR is essential for post-natal

    development

    Knockout mouse: targeted disruption ofVDR gene

    Animals normal at birth, retarded

    growth after birth, then rickets

    Developed alopecia by 7 weeks

    Males and females infertile

    Knockout 1-OHase: rickets, females

    infertileCan somewhat cure with high Ca2+, Pi

    Knockout mouse: 24-OHase

    Defective mineralization of bone

  • 7/29/2019 Vitamin+D+Lecture 1

    27/35

    Non-VDRnuc mediated effects of Vitamin D

    Mediated by a vitamin D receptor on the plasmamembrane called VDRmem

    VDRmem is not related to VDRnuc

    Prefers 1, 25 (OH)2 Vit D3 in the cis form

    Initiates intracellular signaling cascade

    involving PKC, phospholipase C, MAPK

    Increases Calcium absorption by rapid opening

    of Ca2+ and Cl- channels

  • 7/29/2019 Vitamin+D+Lecture 1

    28/35

    Summary

    Low circulating

    calcium increasesPTH secretion

    High calcium inhibits

    PTH secretion

    High 1,25(OH)2vit. D3

    inhibits PTH secretion

    Phosphate regulates

    PTH, but less effect-ively; increased P04

    2-

    increases PTH

    indirectly

  • 7/29/2019 Vitamin+D+Lecture 1

    29/35

    Vitamin D Deficiency

    Serum levels of25(OH)Vit D3

  • 7/29/2019 Vitamin+D+Lecture 1

    30/35

    Dietary Recommendations (2010)

    RDAs established for first time (assuming allVit D obtained from diet)

    Adequate Intakes for infants

    (1 g = 40 IU)

    g vit. D/dayInfants (birth-1 y) (AI) 10

    Children and adults

  • 7/29/2019 Vitamin+D+Lecture 1

    31/35

    Vitamin D Toxicity

    Results from >10,000 IU/day for monthsCannot get this easily from dietary sources

    Unlikely from exposure to sunlight

    Hypercalcemia

    Hyperphosphatemia

    Hypertension

    AnorexiaNausea

    Renal failure

    Death

  • 7/29/2019 Vitamin+D+Lecture 1

    32/35

    Excess exposure to sunlight can produce

    large doses of Vitamin D3 in skin

    Unlikely to result in toxicity due to

    further metabolism of Vit. D

    in skin exposed to sunlight

    lumisterol

    tachysterol

    suprasterol I & IIInactive forms of Vitamin D

  • 7/29/2019 Vitamin+D+Lecture 1

    33/35

    Tolerable upper intake levels of

    Vitamin D (2010):

    Infants 0-1 y 62.5 g/day (2500 IU)

    Children 4-8 y 75 g/day (3000 IU)All others (8 y up) 100 g/day (4000 IU)

    Vitamin D intoxication >150 g/L of25(OH)Vit D3 in serum

    Vitamin D deficiency

  • 7/29/2019 Vitamin+D+Lecture 1

    34/35

    Decreased calcium absorption due to decreased

    calcium intake or decreased vitamin D leads

    to an increased risk of fractures

  • 7/29/2019 Vitamin+D+Lecture 1

    35/35

    Factors preserving BMD

    Calcium and VitaminD supplementation of dietExercise

    Adequate dietary protein levels

    Hormone replacement therapy for

    post-menopausal women bone turnover rate by 10-15% BMD by 2-5% fracture incidence by 25%

    Adequate Vitamin K intake